IU Health

Naoyuki G. Saito, MD, PhD

IU Health

Radiation Oncology

4.7 out of 5 stars (137 ratings)
Accepting New Patients
  • Biography
  • Insurance
  • Locations
  • Specialties & Details
  • Ratings & Reviews
  • Clinical Trials
Biography

Dr. Saito has been a practitioner of radiation oncology since he completed his residency training in 2005. He decided to become a radiation oncologist because he found the specialty both personally rewarding and intellectually stimulating. Dr. Saito enjoys being part of a team of healthcare providers from multiple specialties. He also enjoys teaching medical students and resident physicians. Dr. Saito is fluent in Japanese.

Dr. Saito earned his MD and PhD in molecular biophysics from the Perelman School of Medicine at the University of Pennsylvania, and completed his internal medicine internship and radiation oncology residency at the University of Michigan. Dr. Saito is board certified in radiation oncology by the American Board of Radiology.

His hobbies include travel, gardening, classical music and food. He and his husband, Richard, reside in Fishers, Indiana, with their retired Irish Setter show dog, Martini.

Insurance

Insurance plans accepted by this provider are below.

  • Aetna Medicare Advantage
American Health Plan of Indiana/Majestic Care Management (I-SNP Only)
  • Anthem Blue Cross Blue Shield
  • Anthem Healthy Indiana Plan
  • Anthem Hoosier Care Connect
  • Anthem Hoosier Healthwise
  • Anthem Medicare Advantage
  • Anthem Medicare HMO
  • Anthem Medicare PPO
  • Anthem Pathway Essentials Network
  • Care Source Healthy Indiana Plan
  • Care Source Hoosier Healthwise
Cigna
Community Health Alliance
  • Community Health Network - Employee Plan
Community Health System
  • CorVel/Corecare - Workers Compensation
Coventry/First Health
Deaconess OneCare
  • Encore Workers Compensation
  • Health Alliance Medicare Advantage
  • Humana Medicare Advantage
  • Indiana Health Network - Workers Compensation
  • Indiana University Health - Workers Compensation
  • IU Health Plans Medicare Advantage
Lutheran Preferred
  • Managed Health Services Healthy Indiana Plan
  • Managed Health Services Hoosier Care Connect
  • Managed Health Services Hoosier Healthwise
  • Managed Health Services Medicare Advantage
  • MDWise Excel Healthy Indiana Plan
  • MDWise Excel Hoosier Healthwise
MultiPlan/PHCS
NaphCare
  • Parkview Health Plan Signature Care PPO
  • Point Comfort - Refugee Medical Assistance Program
  • Point Comfort - Unaccompanied Children Program
Sagamore
Select Health Network
SIHO
Suburban Health Organization
  • The Healthcare Group Encircle
  • The Healthcare Group Encore
  • TriCare Select
  • United DSNP
  • United HealthCare
  • United HealthCare Hoosier Care Connect
  • United HMO
  • United Medicare Advantage
  • United PPO
  • VA - CCN via United Healthcare
  • Zing Health CSNP
  • Zing Health DSNP
  • Zing Health HMO
  • Zing Health POS
  • Zing Health PPO

Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.

Locations
Specialties & Details

Specialties:

Radiation Oncology

Hospitals & Affiliations

Hospital Privileges:

IU Health Methodist/IU Health University, IU Health North, IU Health West

Physician Group:

IU Health Physicians

Research

Research Publications
* Information provided by PubMed
Ratings & Reviews
Clinical Trials

Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.

A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) with Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed and Refractory Hematologic Malignancies

View Details

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

View Details

Prospective Validation of a Points Score System Predicting 30-day Survival

View Details